DynamX^™ Drug Eluting Coronary Bioadaptor System is a significant innovation in the treatment of coronary artery disease. Going beyond drug-eluting stents (DES), DynamX represents one of the most significant breakthroughs in implant design in the past 30 years.

DynamX is the first coronary artery implant designed to adapt to vessel physiology by:

• Maintaining the ability for positive adaptive remodeling
• Restoring vessel function
• Allowing for return towards baseline angulation

The loss of vessel movement, which occurs with DES, has been associated with major adverse cardiac events (MACE). By adapting to the vessel, DynamX offers the potential to reduce the incidence of MACE.

UNLIKE TRADITIONAL DES, DYNAMX IS DESIGNED TO ADAPT TO VESSEL PHYSIOLOGY, ACTIVITY LEVEL AND DISEASE PROGRESSION